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Dengue fever is an acute febrile illness caused by the four serotypes (DENV 1-4) of a Flavivirus and transmitted by the bite of Aedes aegypti mosquito. In India, dengue 
causes an epidemic for every 2-5 years [1]. However, there is a 
lack of sufficient guidelines as well as raw literature on the effects 
of dengue in pregnant women and their newborns [2]. Early 
diagnosis and proper treatment of pregnant women with acute 
dengue infection, especially those in the third trimester as well 
as of the neonates with perinatally transmitted dengue, would 
be valuable in the reduction of maternal and neonatal mortality 
rates [3]. We report two cases of neonatal dengue admitted at 




A 5-day-old term neonate was admitted with fever, refusal to feed, 
and shrill cry for the past 1 day. There was no history of rash, 
convulsion, or bleeding from any site. On examination, heart rate 
was 160/min, respiratory rate was 44/min, and axillary temperature 
was 38.5°C with normal perfusion. Neurological examination 
revealed sluggish neonatal reflexes. The neonate was treated 
with a presumptive diagnosis of neonatal sepsis with intravenous 
cefotaxime and netilmicin. Investigation revealed hemoglobin, 
12.4 g%; total leukocyte count, 5600/mm3; differential leukocyte 
count, N22 L72 M6; platelet count, 90,000/mm3; and normal 
micro-erythrocyte sedimentation rate and serum C-reactive 
protein (CRP). Band cells were within normal limits, toxic 
granules were absent.
On day 4 of admission, heart rate was 166/min, respiratory 
rate was 80/min, capillary refill time was prolonged, and the child 
developed feed intolerance and abdominal distension. The child 
was passing stool normally, and peristaltic sounds were within 
normal range. Features of third space fluid loss were evident from 
increasing anasarca, respiratory distress with chest retractions, 
and decreasing urine output. Investigations revealed hemoglobin, 
9.4 g%; platelet count, 20,000/mm3; aspartate aminotransferase, 
780 U/L; and alanine aminotransferase, 500 U/L, Stool for occult 
was blood positive, and ultrasonogram of abdomen revealed ascites.
As there was ongoing dengue epidemic, the case was 
investigated for it. Dengue NS1 and IgM came out to be positive. 
Mother’s history was not contributory and she did not have any 
fever but when tested for the same also had positive IgG and 
IgM for dengue. The shock was managed with appropriate fluid, 
platelet transfusion, and dopamine infusion. Repeat hemoglobin 
was 10.2 g%, total leukocyte count was 6200/mm3, platelet count 
was 170,000/mm3, and CRP <1. The child improved within 72 h 
and was discharged after 10 days of hospital stay.
Case 2
A 4-day-old term male neonate was admitted with lethargy 
and refusal to suck for two days. There was no history of rash, 
convulsion, or bleeding from any site. The mother had low-
grade fever for 2 days just prior to delivery. On examination, the 
neonate had normal heart rate, respiratory rate, temperature, and 
peripheral perfusion but was lethargic. The neonate was managed 
with a presumptive diagnosis of neonatal sepsis with intravenous 
cefotaxime and netilmicin. Initial investigations including 
cerebrospinal fluid study were within normal ranges.
ABSTRACT
Neonates with transplacentally acquired dengue infection often present with subtle features. We report two cases of severe neonatal 
dengue admitted during an outbreak in Kolkata. Both the mothers tested positive for dengue. Both neonates had thrombocytopenia, 
elevated liver aminotransferases, progressive pallor, and third space fluid loss. One neonate required inotropic support (dopamine 
infusion) to manage the shock while the other neonate had to be put on continuous positive airway pressure to manage the increasing 
respiratory distress. Both patients were successfully managed. Neonatal dengue is an important differential diagnosis of neonatal 
sepsis during an outbreak. Early diagnosis and appropriate fluid resuscitation can help in avoiding complications.
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On day 3 of admission, the child started to have respiratory 
distress along with passage of blood-streaked stool along with 
abdominal distension. Peripheral perfusion was also poor. 
Investigation revealed hemoglobin, 7.9 g%; platelet count, 
50,000/mm3; prothrombin time, 19 s; and normal activated partial 
thromboplastin time. Sepsis screen, blood culture, and urine 
culture were negative. Dengue NS1 came out to be positive. 
The mother when tested showed positive IgM and IgG. The 
baby’s chest radiograph revealed right-side pleural effusion, and 
ultrasonogram of abdomen revealed ascites. Initially, feed was 
withheld and he was treated with appropriate fluid management, 
transfusion of platelet and fresh frozen plasma. The child required 
continuous positive airway pressure. After 2 days, the clinical 
condition was stabilized. Repeat tests showed hemoglobin of 
9 g%, total leukocyte count of 6800/mm3, and platelet count 
of 152,000/mm3. Subsequently, he was discharged after 8 days 
of hospital stay.
DISCUSSION
Dengue virus infection results in a spectrum of manifestations 
including fever, myalgia, arthralgia, and leukopenia (dengue 
fever [DF]) in one hand and dengue hemorrhagic fever (DHF) 
and dengue shock syndrome (DSS) with hemorrhage and shock 
on the other hand. DHF and DSS predominantly affect pediatric 
population with the age group of 4-6 years affected most 
commonly [1]. DHF/DSS shows higher incidence in two groups 
of pediatric patients: Children with a past history of DF and 
infants with progressively decreasing levels of transplacentally 
acquire dengue antibody. Various studies reported its rarity in 
early infancy and newborn age groups [4].
Neonatal dengue is different from dengue in other ages 
because of three reasons. First, bleeding and/or shock precipitated 
by dengue can severely complicate the birth injuries encountered 
by both the mother and the newborn during parturition [3]. 
Second, neonates with dengue infection often present with fever 
of short duration, hepatomegaly, thrombocytopenia, circulatory 
insufficiency, excessive bleeding from cord or venepuncture 
sites, and shock. Unfortunately, all these features can be seen 
in various other common neonatal illnesses including bacterial 
sepsis [5]. Hence, a high index of suspicion is needed to prevent 
a potential fatality. Third, if the mother had a previous dengue 
infection, she will have antibodies against dengue in her blood, 
which will be transplacentally acquired by the fetus in utero. 
Postnatally, if this newborn acquires a dengue infection with 
a virus of a different serotype, although it is a primary dengue 
infection, it may behave like a secondary dengue and precipitate 
a DSS [1].
The first case of vertical (transplacental) transmission of 
DF was reported from Tahiti [5]. In a case report of perinatal 
transmission of dengue virus from Puerto Rico [6], of the 
33 cases reported, all developed fever and thrombocytopenia 
in the first two weeks after birth. Increasing number of 
cases of perinatal transmission of DF is being reported from 
Thailand, Malaysia, Puerto Rico, Sri Lanka, Port Sudan, Peru, 
and Brazil [5], yet no consensus has been formed against 
neonatal dengue till now.
Mitra et al. reported that the chance of vertical transmission 
is greatest (and also the risk of maternal bleeding complications) 
if a woman delivers at the height of viremia [7]. It should be 
noted that, while the dengue NS1 antigen becomes positive 
early, the IgM antibody, in postnatally infected newborns, 
requires as long as 5 days to appear [1]. Sirinavin et al. reported 
that the onset of fever in neonates varies from 1 to 11 days 
after birth (average 4 days) and lasts for 1-5 days [8]. In our 
case series, both the neonates presented within 1 week of birth, 
both had complications usually described in severe DF such as 
thrombocytopenia, third space fluid loss, hepatic derangement, 
and respiratory distress.
The exact pathophysiology of neonatal dengue is still 
unclear [3]. If a pregnant woman delivers at or near the 
peak of dengue viremia, intrauterine vertical transmission 
becomes likely [7]. As the maternal protective antibody in 
acute febrile mother is usually of IgM subtype, it cannot 
pass through the placenta to the child and sometimes there 
is insufficient transfer of protective maternal IgG, if formed. 
This increases the likelihood of disease in the newborn. 
As a newborn does not have a mature immune system, both 
humoral as well as cellular responses to the infection are 
slower than older children which probably makes them more 
vulnerable [7] and the disease process becomes more insidious 
and fulminant later than expected in comparison with older 
children. More research work is needed to elaborate the exact 
pathogenesis.
CONCLUSION
This case series may serve to enrich growing medical literature 
regarding the approach to neonatal dengue. During outbreaks of 
dengue in a community, if a neonate presents with non-specific 
features of sepsis, the possibility of neonatal dengue should be 
kept in mind.
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